Skip to main content

Table 1 Study assessment schedule

From: Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation

Assessments

Screening

Baseline

12-week follow-up

24-week follow-up

52-week follow-up

Structured Clinical Interview for DSM-IV Axis II Personality disorders

X

-

-

-

-

Structured Clinical Interview for DSM-IV (SCID-I)a

X

-

-

-

-

Hypomanic Checklist

X

-

-

-

-

Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

X

-

-

-

X

Morisky scale

-

-

X

X

X

Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD)

-

X

X

X

X

Beck Depression Inventory

-

X

X

X

X

Acts of Deliberate Self Harm

-

X

X

X

X

Social Functioning Scale

-

X

X

X

X

EuroQoL-5D

-

X

X

X

X

Side Effect Scale

-

X

X

X

X

Modified Adult Service User Schedule

-

X

X

X

X

  1. DSM-IV Diagnostic and Statistical Manual of Mental Disorders (4th edition), EuroQoL-5D European quality of Life-5 dimensions
  2. aSection on bipolar affective disorder (type I and II)